Meet our speakers

Amina Albeyatti

Head of Business Development

MyClinic.com

Sascha Alilovic

Partner

SHS

Sophie Baratte

CEO

Cellnovo

Assaf Barnea

CEO

Sanara Ventures

Alexander Belcredi

CEO

PhagoMed

Alessio Beverina

Founder and Managing Partner

Panakès Partners

Hubert Birner

Managing Partner

TVM Capital Life Science

Michael Bloch

Counsel

Allen & Overy

John Bowis

International Health Policy Advisor

Thomas Burt

Partner, Crossover Fund

Sofinnova

Pierre Chauvineau

VP, Rhythm Management

Boston Scientific

Maria Chatzou

CEO

Lifebit Biotech


Alain Chevallier

Partner, Life Sciences

Truffle Capital

Robert Chu

CEO & CTO

Embleema

Christopher Cleary

Vice President of Corporate Development

Medtronic

Katherine Cohen

Venture Partner

Panacea Venture

Clive Cookson

Science Editor

Financial Times

Mick Cooper

Healthcare & Life Sciences Analyst

Trinity Delta

Ian Crosbie

CEO

Sequana Medical

Nissim Darvish

Senior Managing Director

Orbimed

John Dawson

CEO

Oxford Biomedica

Fiona de Hemptinne

Venture Partner

UCB Ventures

Olivier Delporte

CEO

Miracor Medical

Francesco De Rubertis

Co-Founder and Partner

Medicxi

Emmanuel de Watteville

General Partner and Co-Founder

BlueOcean Ventures

Dimitri Dimitriou

CEO

Immupharma

Helen Disney

Founder

Unblocked

Matthew Dodds

Vice President, Strategic Planning

Livanova

Lord Drayson

CEO

Sensyne Health

Johnston Erwin

VP Corporate Business Development

Eli Lilly

Martin Frost

CEO

CMR Surgical

Jochen Gann

Head of Global M&A and Corporate Finance

Boehringer Ingelheim

Christian Glennie

Director - Equity Research, Healthcare

Stifel

Jonathan Goldstein

Director, Corporate Research and Ventures

Boston Scientific

Jens Grueger

SVP Global Access

Roche

Shaun Grady

VP Global Business Development

AstraZeneca

Mattias Häggblom

Portfolio Manager - Global Healthcare

Swedbank Robur

Mark Hahnel

Associate Founder

Genomes.io

Deborah Harland

Partner

SR One

John Hodgson

Independent Consultant

Asaf Homossany

Managing Director - EMEA

Nasdaq

Thomas Holm Pedersen

CEO

NMD Pharma

Andrew Hotchkiss

CEO

Immunocore

Jackie Hunter

Chief Executive

BenevolentBio

Anthony Joseph

CTO

Unite Genomics

Christoph Kausch

Founding Partner & CEO

MTIP

Yiannis Kiachopoulos

CEO

Causaly

Sameer Kothari

CEO

Zilico

Lena Krzyzak

Investment Manager

High-Tech Gründerfonds

Lara Koole

Principal

Philips Health Technology Ventures

Dmitry Kuzmin

Managing Partner

4BIO Capital Partners

Chandra Leo

Partner

HBM Partners

Stephan Lensky

CBO

EpimAb

Kit Latham

CEO

Drfocused

Trevor Leighton

Vice President, Market Access

Argenx

Oliver Litzka

Partner

Andera Partners

Carole Longson

Former Director of NICE and CSO

ABPI

Thomas Lonngren

Former Head of EMA and Senior Advisor

NDA Group

Phil L'Huillier

Head of Business Development, Europe, European Innovation Hub

MSD

Tim Luker

Emerging Technology & Innovation, BD

Eli Lilly

Manish Marotkar

Head of Business Development

Siemens Healthineers Digital Ecosystem

John Milad

CEO

QuantaDT

Sean Marett

CBO & CCO

BioNTech

Søren Møller

Managing Partner

Novo Seeds

Angeli Möller

Head of IT Business Partnering Research

Bayer Business Services

Piers Morgan

CFO

Verona Pharma

Savvas Neophytou

Partner & Head of Life Sciences

Deepbridge Capital

Daniel O’Mahony

Partner

Seroba Life Sciences

Geraldine O’Keeffe

Partner

LSP

Natalie Pankova

COO

Project Shivom

Alex Pasteur

Partner

F-Prime Capital Partners

James Peyer

Managing Partner

Apollo Ventures

Martin Pfister

Senior Investment Manager

HTGF

David Pinniger

Fund Manager - Biotechnology

Polar Capital

John Power

CEO & Managing Director

Aerogen Ltd

Pablo Prieto

CTO

Lifebit

Aditya Puri

Partner - Investments

Xeraya Capital

Conrad Rasmus

Co-Founder

Protembis

Dan Rose

CEO

Limflow

Claudio Rumazza

Partner

Innogest Capital

Josep Sanfeliu

Managing Partner

Asabys Partners

Dominic Schmidt

Partner

Syncona Investment Management

Matthew Scholz

CEO

Oisin Biotechnologies

Nerida Scott

New Ventures And Transactions

J&J

Graziano Seghezzi

Managing Partner

Sofinnova Partners

Johan Sellström

Co-Founder

CareChain

Nigel Sheail

Head BD&L

Novartis

Harpreet Singh

CEO

Immatics

Yochi Slonim

CEO

Anima Biotech

Bobby Soni

Partner - Life Science Investments

IP Group

Nikolaj Sorenson

CEO

Orexo

Ivo Staijen

Portfolio Manager

HBM Partners

Casey Swerner

Analyst

DN Capital

Chas Taylor

CEO

Veryan

Anton Ussi

Director Operations & Finance

EATRIS

Laurent Vandebrouck

CEO

Chronolife and Connected Health Development

Edward Van Wezel

Managing Partner

BioGeneration Ventures

Gary Waanders

Managing Director - UK Healthcare Research

Bryan, Garnier & Co.

Susana Waesch

VP Quality Management & Regulatory Affairs

Ypsomed AG

Franz Warner Haas

COO

CureVac

Boris Zaitra

Global Head of M&A

Roche